Influence of disease features on adherence to prophylactic migraine medication

Acta Neurologica Scandinavica

Volumn 118, Issue 6, 2008, Pages 367-372

  Linde, M ^a,b   Jonsson, P ^a   Hedenrud, T ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Cephalea Headache Centre   (Sweden)

Author keywords

Adherence; Compliance; Migraine; Predictors; Prophylaxis

Indexed keywords

AMITRIPTYLINE; ATENOLOL; CITALOPRAM; CYPROHEPTADINE; ESTROGEN; FLUNARIZINE; FLUOXETINE; GABAPENTIN; METHYSERGIDE; METOPROLOL; NAPROXEN; PIZOTIFEN; PROPRANOLOL; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONOTHERAPY; PAIN ASSESSMENT; PRESCRIPTION; PROPHYLAXIS; SELF REPORT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE OF ONSET; AGED; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN CLINICS; PAIN MEASUREMENT; PATIENT COMPLIANCE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 51849159694     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01042.x     Document Type: Article

References (36)

1. Silberstein S, Goadsby P. Migraine: preventive treatment. Cephalalgia 2002 22 : 491 512.
2. Tomkins G, Jackson J, O'Malley P, Balden E, Santoro J. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001 111 : 54 63.
3. Evers S, Afra J, Frese A et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 2006 13 : 560 72.
4. Linde M. Migraine: a review and future directions for treatment. Acta Neurol Scand 2006 114 : 71 83.
5. D'Amico D, Solari A, Usai P et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 2006 26 : 691 6.
6. Diener H, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs 1998 56 : 811 8.
7. Rahimtoola H, Buurma H, Tijssen C, Leufkens H, Egberts A. Migraine prophylactic medication usage patterns in the Netherlands. Cephalalgia 2003 23 : 293 301.
8. Eraker S, Kirscht J, Becker M. Understanding and improving patient compliance. Ann Intern Med 1984 100 : 258 68.
9. Steiner T, Catarci T, Hering R, Whitmarsh T, Couturier E. If migraine prophylaxis does not work, think about compliance. Cephalalgia 1994 14 : 463 4.
10. Aubé M. Improving patient compliance to prophylactic migraine therapy. Can J Neurol Sci 2002 29 (Suppl.2 40 3.
11. Nichol M, Venturini F, Sung J. A critical evaluation of the literature on medication compliance. Ann Pharmacother 1999 33 : 531 40.
12. Haynes R, Yao X, Degani A, Kripalani S, Garg A, McDonald H. Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005 19 : CD000011.
13. Rains J, Lipchick G, Penzien D. Behavioral facilitation of medical treatment for headache - part I: review of headache treatment compliance. Headache 2006 46 : 1387 94.
14. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia 2003 23 : 833 41.
15. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004 24 (Suppl 1 1 160.
16. Horne R, Weinman J. Predicting treatment adherence: an overview of theoretical models. In : Myers L, Midence K, eds. Adherence to treatment in medical conditions. London : Harwood academic, 1998 25 50.
17. George J, Kong D, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005 128 : 3198 204.
18. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002 17 : 17 32.
19. Byrne M, Walsh J, Murphy A. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res 2005 58 : 403 15.
20. Horne R. Assessing perceptions of medication: psychological perspectives. In : McGavock H, ed. Handbook of drug use research methodology. Newcastle upon Tyne : The United Kingdom Drug Utilisation Research Group, 2000 299 319.
21. Garber M, Nau D, Erickson S, Aikens J, Lawrence J. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004 42 : 649 52.
22. Cline C, Björck-Linné A, Israelsson B, Willenheomer R, Erhardt L. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999 1 : 145 9.
23. Cramer J, Mattson R. Monitoring compliance with antiepileptic drug therapy. In : Cramer J, Spilker B, eds. Patient compliance in medical practice and clinical trial. New York : Raven Press, 1991 123 37.
24. Sweden S. Statistical yearbook of Sweden 2006. Örebro : Statistics Sweden, 2005 563 71.
25. Dahlöf C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 2001 21 : 664 71.
26. Linde M, Dahlöf C. Attitudes and burden of disease among self-considered migraineurs. A nation-wide, population-based survey in Sweden. Cephalalgia 2004 24 : 455 65.
27. Mulleners W, Whitmarsh T, Steiner T. Non-compliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 1998 18 : 52 6.
28. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999 47 : 555 67.
29. Rudd P, Ramesh J, Bryant-Kosling C, Guerrero D. Gaps in cardiovascular medication: the tip of the iceberg. J Gen Intern Med 1993 8 : 659 66.
30. Massiou H. Migraine medication attributes are important for patient compliance. Drugs Today 2003 39 (Suppl. D 25 9.
31. O'Carroll R, McGregor L, Swanson V, Masterton G, Hayes P. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl Surg 2006 12 : 1862 8.
32. Misdrahi D, Llorca P, Lançon C, Bayle F. Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications. Encephale 2002 28 : 266 72.
33. Rosa A, Marco M, Fachel J, Kapczinski F, Stein A, Barros H. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge of bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 2007 30 : 217 24.
34. Hedenrud T, Jonsson P, Linde M. Beliefs about medicines and adherence among Swedish migraineurs. Ann Pharmacother 2008 42 : 39 45.
35. Goadsby P. The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci 1999 26 (Suppl. 3 20 6.
36. MacGregor E. The doctor and the migraine patient: improving compliance. Neurology 1997 48 (Suppl. 3 16 20.